The Third Vaccine, and Vaccine Choice

a16z’s Alex Rampell and Joe Schmidt sit down with Lightfield co-founder and CEO Keith Peiris to discuss what it takes to rethink the CRM for an AI-native world, and the unusual pivot that got him there.Keith previously built Tome to 25 million users, but eventually walked away fr ... Show More

This interview with Stripe cofounders John and Patrick Collison originally aired on TBPN. They discuss Stripe's 34% growth and new employee tender offer, how agent commerce and stablecoins may require high-throughput blockchains built for millions of transactions per second, and ... Show More

Anish Acharya speaks with Peter Yang, creator and product lead at Roblox, about how personal AI agents are replacing the apps we open every day, why coding agents feel like slot machines, and what happens when the cost of building software drops to near zero. They discuss why fut ... Show More

The Johnson & Johnson vaccine for COVID-19 is a one-dose viral vector vaccine that's about as effective as the mRNA vaccines available. Learn how it works in this episode of BrainStuff. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/lis ... Show More

Several vaccine companies have announced promising early evidence that their vaccines are effective at preventing symptoms of a coronavirus infection. So what comes next? CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to vaccine creator and virology and immunology expert, ... Show More

Dr. Dan Barouch is the director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston, and is helping develop Johnson & Johnson’s vaccine candidate. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to him about how this vaccine is ... Show More

Skip Montreux and Samantha Vega report on recent developments in the race to develop a vaccine for COVID-19. Audio script available at downtobusinessenglish.com Visit Apple Podcasts to subscribe to Down to Business English, rate the show, and leave a comment. Visit our website or ... Show More

<p>You might have heard about the COVID variants that have some people worried, and how effective the current vaccine will be against them. But not to worry, we’ve got the sweet sweet data from the Lancet, and some good news regarding the (specifically Pfizer) vaccine. And if you ... Show More

<p>Link to the original lesson: https://youtu.be/utvGDjtjaJo</p> <p>Here is a lesson that you can use to help with your English comprehension. &nbsp;</p> <p>In this lesson, I talk about who is getting vaccinated here in the United States and which vaccines we have. &nbsp;&nbsp;</ ... Show More

The FDA vaccine advisers recommended authorization of Johnson & Johnson’s coronavirus vaccine. In the U.S., the single-shot showed an overall efficacy of 72% in preventing moderate to severe disease and 85% effective in preventing severe disease. CNN’s Chief Medical Correspondent ... Show More